1. Home
  2. CCB vs CSTL Comparison

CCB vs CSTL Comparison

Compare CCB & CSTL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Coastal Financial Corporation

CCB

Coastal Financial Corporation

N/A

Current Price

$43.26

Market Cap

633.6M

Sector

Finance

ML Signal

N/A

Logo Castle Biosciences Inc.

CSTL

Castle Biosciences Inc.

N/A

Current Price

$37.13

Market Cap

722.8M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
CCB
CSTL
Founded
1997
2007
Country
United States
United States
Employees
N/A
N/A
Industry
Major Banks
Medical Specialities
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
633.6M
722.8M
IPO Year
2018
2019

Fundamental Metrics

Financial Performance
Metric
CCB
CSTL
Price
$43.26
$37.13
Analyst Decision
Buy
Strong Buy
Analyst Count
4
10
Target Price
★ $51.00
$46.70
AVG Volume (30 Days)
198.0K
★ 316.3K
Earning Date
10-29-2026
11-05-2026
Dividend Yield
N/A
N/A
EPS Growth
★ N/A
N/A
EPS
N/A
★ N/A
Revenue
N/A
★ $344,229,000.00
Revenue This Year
$4.17
$8.68
Revenue Next Year
$20.89
$12.08
P/E Ratio
N/A
★ N/A
Revenue Growth
N/A
★ 3.66
52 Week Low
$35.56
$17.72
52 Week High
$120.05
$44.28

Technical Indicators

Market Signals
Indicator
CCB
CSTL
Relative Strength Index (RSI) 46.32 59.47
Support Level $36.09 $31.56
Resistance Level $50.78 $37.42
Average True Range (ATR) 1.90 1.62
MACD 0.39 0.46
Stochastic Oscillator 32.15 73.85

Price Performance

Historical Comparison
CCB
CSTL

About CCB Coastal Financial Corporation

Coastal Financial Corp is a bank holding company. Through its subsidiaries, the company conducts its business in three reportable segments which include, Community Bank, CCBX, and Treasury and Administration. The Community Bank segment includes all community banking activities, with a primary focus on providing various banking products and services to consumers and small to medium-sized businesses. The CCBX segment provides Banking as a Service (BaaS) that allows its broker dealers and digital financial service partners to offer their customers banking services, and the Treasury and administration segment includes treasury management, overall administration, and all other aspects of the company.

About CSTL Castle Biosciences Inc.

Castle Biosciences Inc is a molecular diagnostics company. The group provides test solutions for the diagnosis and treatment of dermatologic cancers, Barrett's esophagus (BE), and uveal melanoma. The product portfolio of the company includes DecisionDx-Melanoma, a risk stratification gene expression profile (GEP) test; DecisionDx-SCC, a risk stratification test for cutaneous squamous cell carcinoma; MyPath Melanoma, a diagnostic GEP test for use in patients with difficult-to-diagnose melanocytic lesions; and TissueCypher, a test to predict future development of progression of high-grade dysplasia and/or esophageal cancer. The company derives revenues through the delivery of test reports for its molecular diagnostic tests.

Share on Social Networks: